Chronic Lymphocytic Leukemia: Treatment Options for Patients With Refractory Disease

Por Motta, Marina, Wierda, William G., Ferrajoli, Alessandra
Publicado no Cancer (2009)

Spotlight on ibrutinib and its potential in frontline treatment of chronic lymphocytic leukemia

Por Khan, Maliha, Gibbons, Jamie L, Ferrajoli, Alessandra
Publicado no Onco Targets Ther (2017)

Invasive Fungal Infections in Acute Leukemia

Por Bhatt, Vijaya R., Viola, George M., Ferrajoli, Alessandra
Publicado em 2011

The Role of Monoclonal Antibodies in the Management of Leukemia

Por Al-Ameri, Ali, Cherry, Mohamad, Al-Kali, Aref, Ferrajoli, Alessandra
Publicado em 2010

BCR Signaling Inhibitors: an Overview of Toxicities Associated with Ibrutinib and Idelalisib in Patients with Chronic Lymphocytic Leukemia

Por Falchi, Lorenzo, Baron, Jessica M., Orlikowski, Carrie Anne, Ferrajoli, Alessandra
Publicado no Mediterr J Hematol Infect Dis (2016)

Experience With Rituximab Immunotherapy as an Early Intervention in Patients With Rai Stage 0 to II Chronic Lymphocytic Leukemia

Por Ferrajoli, Alessandra, Keating, Michael J., O’Brien, Susan, Cortes, Jorge, Thomas, Deborah A.
Publicado no Cancer (2011)

Alemtuzumab by Continuous Intravenous Infusion Followed by Subcutaneous Injection Plus Rituximab in the Treatment of Patients With Chronic Lymphocytic Leukemia Recurrence

Por Faderl, Stefan, Ferrajoli, Alessandra, Wierda, William, O'Brien, Susan, Lerner, Susan, Keating, Michael J.
Publicado no Cancer (2010)

Fludarabine, Cyclophosphamide, Mitoxantrone plus Rituximab (FCM-R) in Frontline CLL < 70 Years

Por Faderl, Stefan, Wierda, William, O'Brien, Susan, Ferrajoli, Alessandra, Lerner, Susan, Keating, Michael J.
Publicado no Leuk Res (2009)

microRNA Therapeutics in Cancer — An Emerging Concept

Por Shah, Maitri Y., Ferrajoli, Alessandra, Sood, Anil K, Lopez-Berestein, Gabriel, Calin, George A.
Publicado no EBioMedicine (2016)

A Phase 2 Study of Yttrium-90 Ibritumomab Tiuxetan (Zevalin) in Patients With Chronic Lymphocytic Leukemia

Por Jain, Nitin, Wierda, William, Ferrajoli, Alessandra, Wong, Franklin, Lerner, Susan, Keating, Michael, O’Brien, Susan
Publicado no Cancer (2009)

Fludarabine, cyclophosphamide, and rituximab (FCR) plus GM-CSF as frontline treatment for patients with Chronic Lymphocytic Leukemia

Por Strati, Paolo, Ferrajoli, Alessandra, Lerner, Susan, O’Brien, Susan, Wierda, William, Keating, Michael J, Faderl, Stefan
Publicado no Leuk Lymphoma (2013)

Second Cancers and Richter’s Transformation are the Leading Causes of Death in Patients with Trisomy 12 Chronic Lymphocytic Leukemia

Por Strati, Paolo, Abruzzo, Lynne V., Wierda, William G., O’Brien, Susan, Ferrajoli, Alessandra, Keating, Michael J.
Publicado no Clin Lymphoma Myeloma Leuk (2015)

The Prognostic Difference of Monoallelic Versus Biallelic Deletion of 13q in Chronic Lymphocytic Leukemia

Por Garg, Ravin, Wierda, William, Ferrajoli, Alessandra, Abruzzo, Lynne, Pierce, Sherry, Lerner, Susan, Keating, Michael, O’Brien, Susan
Publicado no Cancer (2011)

Myelosuppression After Frontline Fludarabine, Cyclophosphamide, and Rituximab in Patients With Chronic Lymphocytic Leukemia: Analysis of Persistent and New-Onset Cytopenia

Por Strati, Paolo, Wierda, William, Burger, Jan, Ferrajoli, Alessandra, Tam, Constantine, Lerner, Susan, Keating, Michael J., O’Brien, Susan
Publicado no Cancer (2013)

Signal Transducer and Activator of Transcription (STAT)-3 Activates Nuclear Factor (NF)-κB in Chronic Lymphocytic Leukemia Cells

Por Liu, Zhiming, Hazan-Halevy, Inbal, Harris, David M., Li, Ping, Ferrajoli, Alessandra, Faderl, Stefan, Keating, Michael J., Estrov, Zeev
Publicado em 2011

Clinical Characteristics, Response to Therapy, and Survival of African American Patients Diagnosed With Chronic Lymphocytic Leukemia: Joint Experience of the MD Anderson Cancer Cen...

Por Falchi, Lorenzo, Keating, Michael J., Wang, Xuemei, Coombs, Catherine C., Lanasa, Mark C., Strom, Sara, Wierda, William G., Ferrajoli, Alessandra
Publicado no Cancer (2013)

Report of a phase 1/2 study of a combination of azacitidine and cytarabine in acute myelogenous leukemia and high-risk myelodysplastic syndromes

Por BORTHAKUR, GAUTAM, HUANG, XUELIN, KANTARJIAN, HAGOP, FADERL, STEFAN, RAVANDI, FARHAD, FERRAJOLI, ALESSANDRA, TORMA, RITVA, MORRIS, GAIL, BERRY, DONALD, ISSA, JEAN-PIERRE
Publicado em 2010

Activity of Decitabine in Patients with Myelodysplastic Syndrome Previously Treated with Azacitidine

Por Borthakur, Gautam, El Ahdab, Samih Y., Garcia-Manero, Guillermo, Ravandi, Farhad, Ferrajoli, Alessandra, Newman, Beth A, Issa, Jean-Pierre, Kantarjian, Hagop
Publicado em 2008

Impaired bactericidal but not fungicidal activity of polymorphonuclear neutrophils in patients with chronic lymphocytic leukemia

Por Kontoyiannis, Dimitrios P., Georgiadou, Sarah P., Wierda, William G., Wright, Susan, Albert, Nathaniel D., Ferrajoli, Alessandra, Keating, Michael, Lewis, Russell E.
Publicado em 2013

Clofarabine Combinations as Acute Myeloid Leukemia Salvage Therapy

Por Faderl, Stefan, Ferrajoli, Alessandra, Wierda, William, Huang, Xuelin, Verstovsek, Srdan, Ravandi, Farhad, Estrov, Zeev, Borthakur, Gautam, Kwari, Monica, Kantarjian, Hagop M.
Publicado em 2008